Biotech the right medicine for this market: Lehmann

Now watching

Next video starts in : 7 Play

Biotech the right medicine for this market: Lehmann

Biotech the right medicine for this market: Lehmann
Replay video
Up next

GM appeases recall victims but still faces two big hurdles

Unlock your personal NFL Now stream by signing in to NFL.com

Biotech the right medicine for this market: Lehmann

by Breakout Videos 2:34 mins

Biotech the right medicine for this market: Lehmann

by Breakout Videos 2:34 mins

Mark Lehmann of JMP Securities on why biotech will give your portfolio a shot in the arm

Market Movers

  1. 11:20

    Investors focus on autos; Apple's music comeback; Fitbit's IPO

  2. 2:05

    Health insurers propose rate hikes

  3. 1:36

    Fitbit seeks $358M in IPO

  4. 1:58

    Apple to offer $10/mo streaming music service

  5. 1:36

    Dollar General pops on profit beat; PVH in vogue; Big Tobacco ordered to pay up

  6. 10:48

    Investors eye consumer spending; Microsoft's new OS; High priced drugs under scrutiny

Personal Finance

Market Movers

  1. 11:20

    Investors focus on autos; Apple's music comeback; Fitbit's IPO

  2. 2:05

    Health insurers propose rate hikes

  3. 1:36

    Fitbit seeks $358M in IPO

  4. 1:58

    Apple to offer $10/mo streaming music service

  5. 1:36

    Dollar General pops on profit beat; PVH in vogue; Big Tobacco ordered to pay up

  6. 10:48

    Investors eye consumer spending; Microsoft's new OS; High priced drugs under scrutiny